May 19 - Commure, a California-based firm developing AI for healthcare administration, said it secured $70 million in a new financing round and now carries a $7 billion post-money valuation. The round was led by General Catalyst and also included participation from Sequoia Capital, Morgan Stanley and the law firm Kirkland & Ellis.
The company positions its technology as agentic AI, a class of systems that can plan, decide and act autonomously rather than only responding to prompts. Commure said its revenue cycle management platform - designed to handle patient billing and payment tracking - already completes more than 85% of required tasks without human intervention.
Commure reported its tools are embedded across more than 500 healthcare organizations and in roughly 3,000 care sites. The firm explained it will direct the newly raised capital toward scaling its revenue cycle and practice management platform and extending its AI infrastructure into healthcare markets outside its current footprint.
Revenue cycle management, as the company described it, refers to the administrative process of managing patient billing and tracking payments within healthcare organizations. Commure highlighted automation of those workflows as a core capability of its platform.
The financing round and valuation reflect investor interest in agentic AI applications aimed at streamlining healthcare operations. In announcing the raise, the company framed the capital as support for product scaling and international expansion efforts.
Context and implications
Commure's announcement centers on two concrete metrics provided by the company: a post-money valuation of $7 billion and a $70 million capital raise led by General Catalyst, with Sequoia Capital, Morgan Stanley and Kirkland & Ellis named as participants. The firm supplied adoption data indicating its revenue cycle platform performs over 85% of tasks autonomously and is in use across more than 500 organizations and approximately 3,000 sites.
The company stated its intention to allocate proceeds to scale its revenue cycle and practice management offerings and to expand its AI infrastructure into global healthcare markets.